Cargando…
Identification of microtubule-associated biomarkers in diffuse large B-cell lymphoma and prognosis prediction
Background: Diffuse large B-cell lymphoma (DLBCL) is a genetically heterogeneous disease with a complicated prognosis. Even though various prognostic evaluations have been applied currently, they usually only use the clinical factors that overlook the molecular underlying DLBCL progression. Therefor...
Autores principales: | Wu, Wenqi, Liu, Su, Tian, Linyan, Li, Cheng, Jiang, Yanan, Wang, Jinhuan, Lv, Yangyang, Guo, Jing, Xing, Donghui, Zhai, Yixin, Sun, Huimeng, Li, Yuhang, Zhang, Luying, He, Xiang, Luo, Kaiping, Zhan, Hongjie, Zhao, Zhigang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9902697/ https://www.ncbi.nlm.nih.gov/pubmed/36761693 http://dx.doi.org/10.3389/fgene.2022.1092678 |
Ejemplares similares
-
Corrigendum: Identification of microtube-associated biomarkers in diffuse large B-cell lymphoma and prognosis prediction
por: Wu, Wenqi, et al.
Publicado: (2023) -
A Novel Defined Super-Enhancer Associated Gene Signature to Predict Prognosis in Patients With Diffuse Large B-Cell Lymphoma
por: Xu, Hong, et al.
Publicado: (2022) -
Immunophenotypic Landscape and Prognosis-Related mRNA Signature in Diffuse Large B Cell Lymphoma
por: Jiang, Yanan, et al.
Publicado: (2022) -
Prognostic Significance of Ribosome-related Genes Signature in Diffuse Large B Cell Lymphoma
por: Wu, Wenqi, et al.
Publicado: (2023) -
Efficacy of chimeric antigen receptor T cell therapy and autologous stem cell transplant in relapsed or refractory diffuse large B-cell lymphoma: A systematic review
por: Tian, Linyan, et al.
Publicado: (2023)